PotentiaMetrics offers a decision‑support platform that combines clinical guidelines, real‑world outcomes, and cost data to generate patient‑specific treatment recommendations for complex diseases such as cancer, renal and cardiovascular conditions. The interactive dashboard lets clinicians and patients compare efficacy, safety, and expense of therapy options, supporting shared decision‑making and more personalized care.
Funding
$750K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with complex conditions such as cancer, end‑stage renal disease, and cardiovascular disease often face a lack of clear, personalized information about which treatments are most effective for their specific situation and at what cost. This uncertainty hampers shared decision‑making and can lead to suboptimal adherence and outcomes.
Solution
PotentiaMetrics provides a data‑driven decision support platform that integrates clinical guidelines, real‑world outcomes, and cost data to generate individualized treatment insights. The system evaluates the effectiveness of therapies for a given patient profile, taking into account clinical evidence, patient preferences, and economic considerations. Clinicians and patients can explore these personalized, values‑based options through an intuitive interface, facilitating more informed discussions and shared decisions. By translating complex multidimensional data into clear recommendations, the platform aims to improve treatment adherence, quality of life, and overall care efficiency for individuals with high‑complexity diseases.
Target Audience
Primary users are oncologists, nephrologists, cardiologists, and other specialists who manage patients with complex, high‑risk conditions, as well as health plans and employer‑based health programs seeking to support personalized care decisions.
Features
- Integration of industry‑sanctioned clinical guidelines with real‑world outcome datasets
- Cost analysis module that presents treatment expenses alongside efficacy metrics
- Patient‑specific recommendation engine that accounts for clinical, personal, and financial factors
- Interactive dashboard for clinicians and patients to compare treatment scenarios
- Support for multiple disease areas, including oncology, nephrology, and cardiology